Events
Duane Morris Patent Agent Dr. Johann Lin to Speak on Patent Eligibility of Diagnostic/Personalized Medicine Methods
August 17, 2012 | Singapore
| IP Academy
Duane Morris patent agent Johann Yi-Der Lin, Ph.D. will be the featured speaker at an IP Academy program, "Is There Life After Prometheus?," to be held on August 17, 2012, at the IP Academy in Singapore.
About the Program
How can Diagnostic, Personalized Medicine and Biotechnology companies protect their inventions?
In Prometheus, the U.S. Supreme Court addressed the patent-eligibility of diagnostic/personalized medicine methods that were characterized as being based on a law of nature. While the court invalidated the patent claims at issue, questions remained as to how this holding will be applied to other cases, and whether it may still be possible to patent methods in the diagnostic/personalized medicine sector.
In Myriad, the Federal Circuit addressed the patent-eligibility of DNA isolated from nature that is associated with a particularly aggressive form of breast cancer. While the Federal Circuit upheld the claims, it is not clear whether it—or the U.S. Supreme Court—will uphold them again in view of Prometheus. If not, will diagnostic and biotechnology companies have other ways of protecting their inventions?
Join us for this programme to gain a deeper understanding of the recent developments in the patent-eligibility of diagnostic/personalized medicine and biotechnology inventions.
Who Should Attend
This course is targeted at patent agents and patent professionals in Singapore whose work involves the US patent system. It is also targeted at those who coordinate patent filing in the US for their employer or who are tracking patent filing in the US for their employer.
For more information or to register online, please visit the IP Academy website.
